Sei Investments CO Xencor Inc Transaction History

Sei Investments CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$25.95 - $36.95 $211,103 - $300,588	8,135 New	8,135 $226,000
Q4 2020 Feb 08, 2021	SELL	$36.63 - $47.63 $732,600 - $952,600	-20,000 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$30.09 - $43.02 $601,800 - $860,400	20,000 New	20,000 $776,000
Q1 2019 May 15, 2019	SELL	$27.85 - $38.09 $46,927 - $64,181	-1,685 Closed	0 $0
Q3 2018 Nov 08, 2018	SELL	$35.69 - $47.65 $72,629 - $96,967	-2,035 Reduced 54.7%	1,685 $66,000
Q2 2018 Aug 03, 2018	BUY	$28.41 - $42.41 $105,685 - $157,765	3,720 New	3,720 $138,000

214

71.8M

2.5K

7.9K

Ticker XNCR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,698,100
Market Cap $1.09B
Description
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.